COVID-19 and Genitourinary Cancers - Results from #120

Cancer and Risk of COVID-19 Through a General Community Survey. September 3, 2020

Urological service provision during the COVID-19 period: the experience from an Irish tertiary centre. September 2, 2020

COVID-19 pandemic: Implications for radionuclide therapy in Nuclear Medicine departments. September 1, 2020

Systematic Review: Safety of Intravesical Therapy for Bladder Cancer in the Era of COVID-19. August 28, 2020

Delivery of urological services (telemedicine and urgent surgery) during COVID-19 lockdown: experience and lessons learnt from a university hospital in United Kingdom. August 27, 2020

Sex Hormones and Hormone Therapy during COVID-19 Pandemic: Implications for Patients with Cancer. August 26, 2020

Systemic treatment of advanced/metastatic renal cell carcinoma in the context of SARS-CoV-2 pandemic: recommendations from the interdisciplinary working group for renal tumors (IAG-N). August 25, 2020

Chemotherapy and COVID-19 Outcomes in Patients With Cancer. August 24, 2020

Coronavirus Spectrum Infections (COVID-19, MERS, SARS) in Cancer Patients: A Systematic Review of the Literature. August 21, 2020

Challenges of Treating a Patient With Advanced Prostate Cancer During the COVID-19 Pandemic. August 18, 2020

Timing and delay of radical prostatectomy do not lead to adverse oncologic outcomes: results from a large European cohort at the times of COVID-19 pandemic. August 17, 2020

Outreach and influence of surgical societies` recommendations on minimally invasive surgery during the COVID-19 pandemic - an anonymized international urologic expert inquiry. August 14, 2020

Are all patients with cancer at heightened risk for severe Coronavirus Disease 2019 (COVID-19)? August 10, 2020

NIH Clinical Trial Testing Remdesivir Plus Interferon Beta-1a for COVID-19 Treatment Begins, Adaptive COVID-19 Treatment Trial 3 (ACTT 3) August 6, 2020

Management of germ cell tumors during the outbreak of the novel coronavirus disease-19 pandemic: a survey of international expertise centers. August 5, 2020

SARS-CoV-2 infection in immunocompromised patients: humoral versus cell-mediated immunity. August 4, 2020

Protecting healthcare workers during the COVID-19 pandemic with new technologies: acceptability, feasibility and impact of the HoloLens2 mixed reality headset across multiple clinical settings. August 3, 2020

Crosstalk between COVID-19 and prostate cancer. August 3, 2020

Urologic oncology practice during COVID-19 pandemic: A systematic review on what can be deferrable vs. nondeferrable. July 30, 2020

Urological Services in the Era of COVID-19. July 29, 2020

Page 7 of 17

email news signup